Hedgehog pathway inhibitors as targeted cancer therapy and strategies to overcome drug resistance

NM Nguyen, J Cho - International Journal of Molecular Sciences, 2022 - mdpi.com
Hedgehog (Hh) signaling is a highly conserved pathway that plays a vital role during
embryonic development. Recently, uncontrolled activation of this pathway has been …

Sonic hedgehog signaling in cerebellar development and cancer

W Wang, R Shiraishi, D Kawauchi - Frontiers in Cell and …, 2022 - frontiersin.org
The sonic hedgehog (SHH) pathway regulates the development of the central nervous
system in vertebrates. Aberrant regulation of SHH signaling pathways often causes …

New drug delivery systems developed for brain targeting

SU Rawal, BM Patel, MM Patel - Drugs, 2022 - Springer
The blood-brain barrier (BBB) and the blood-cerebrospinal fluid barrier (BCSF) are two of
the most complex and sophisticated concierges that defend the central nervous system …

[HTML][HTML] TMZ magnetic temperature-sensitive liposomes-mediated magnetothermal chemotherapy induces pyroptosis in glioblastoma

J Yao, X Feng, X Dai, G Peng, Z Guo, Z Liu… - … , Biology and Medicine, 2022 - Elsevier
Glioblastoma (GBM) is the most fatal and common type of primary malignant tumors in
central nervous system. Chemotherapy drugs are difficult to reach the encephalic region …

SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma

L Lospinoso Severini, E Loricchio, S Navacci… - Cell Death & …, 2024 - nature.com
Abstract The Sonic Hedgehog (SHH) pathway is crucial regulator of embryonic development
and stemness. Its alteration leads to medulloblastoma (MB), the most common malignant …

Medulloblastoma targeted therapy: From signaling pathways heterogeneity and current treatment dilemma to the recent advances in development of therapeutic …

Q Wang, X Xin, Q Dai, M Sun, J Chen… - Pharmacology & …, 2023 - Elsevier
Medulloblastoma (MB) is a major pediatric malignant brain tumor that arises in the
cerebellum. MB tumors exhibit highly heterogeneous driven by diverse genetic alterations …

Nanoparticles for diagnosis and target therapy in pediatric brain cancers

C Guido, C Baldari, G Maiorano, A Mastronuzzi… - Diagnostics, 2022 - mdpi.com
Pediatric brain tumors represent the most common types of childhood cancer and novel
diagnostic and therapeutic solutions are urgently needed. The gold standard treatment …

Elevated NF-κB/SHh/GLI1 signature denotes a worse prognosis and represent a novel potential therapeutic target in advanced prostate cancer

D Vecchiotti, D Verzella, M Di Vito Nolfi, D D'Andrea… - Cells, 2022 - mdpi.com
Prostate cancer (PCa) is the second most frequent cancer in men worldwide. NF-κB seems
to play a key role in cell survival, proliferation and invasion, sustaining the heterogeneous …

[HTML][HTML] Nanoparticles for drug and gene delivery in pediatric brain tumors' cancer stem cells: Current knowledge and future perspectives

L Abballe, Z Spinello, C Antonacci, L Coppola, E Miele… - Pharmaceutics, 2023 - mdpi.com
Primary malignant brain tumors are the most common solid neoplasm in childhood. Despite
recent advances, many children affected by aggressive or metastatic brain tumors still …

Signaling pathways and therapeutic strategies in advanced basal cell carcinoma

G Vallini, L Calabrese, C Canino, E Trovato… - Cells, 2023 - mdpi.com
Non-melanoma skin cancers (NMSCs) are the most common human neoplasms world-wide.
In detail, basal cell carcinoma (BCC) is the most frequent malignancy in the fair-skinned …